Noel Courage and Ainslie Parsons coauthored an article "Data protection update: ups and downs in the exclusivity term" by The Life Sciences Lawyer
May 4, 2020
It is important to innovate drug companies to take advantage of available exclusivities, to ensure that they can recoup investment from the costly drug development process.
Click here to read full article.
This article was first published in The Life Sciences Lawyer magazine, Issue 2, 2020.